ATE207921T1 - Verfahren zur herstellung von tetrahydroindolizinen - Google Patents
Verfahren zur herstellung von tetrahydroindolizinenInfo
- Publication number
- ATE207921T1 ATE207921T1 AT97919674T AT97919674T ATE207921T1 AT E207921 T1 ATE207921 T1 AT E207921T1 AT 97919674 T AT97919674 T AT 97919674T AT 97919674 T AT97919674 T AT 97919674T AT E207921 T1 ATE207921 T1 AT E207921T1
- Authority
- AT
- Austria
- Prior art keywords
- compound
- tetrahydroindolizine
- producing
- solvent
- useful
- Prior art date
Links
- ZBPHPBWGQALQCS-UHFFFAOYSA-N 1,2,3,5-tetrahydroindolizine Chemical compound C1C=CC=C2CCCN21 ZBPHPBWGQALQCS-UHFFFAOYSA-N 0.000 title 1
- 238000004519 manufacturing process Methods 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 4
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 abstract 3
- 239000002904 solvent Substances 0.000 abstract 2
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 abstract 1
- MEKOFIRRDATTAG-UHFFFAOYSA-N 2,2,5,8-tetramethyl-3,4-dihydrochromen-6-ol Chemical compound C1CC(C)(C)OC2=C1C(C)=C(O)C=C2C MEKOFIRRDATTAG-UHFFFAOYSA-N 0.000 abstract 1
- 239000002841 Lewis acid Substances 0.000 abstract 1
- 150000004703 alkoxides Chemical class 0.000 abstract 1
- 125000000217 alkyl group Chemical group 0.000 abstract 1
- 239000002246 antineoplastic agent Substances 0.000 abstract 1
- -1 carbonate diester Chemical class 0.000 abstract 1
- 150000007517 lewis acids Chemical class 0.000 abstract 1
- 239000002184 metal Substances 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP10725196 | 1996-04-26 | ||
| JP10725296 | 1996-04-26 | ||
| PCT/JP1997/001428 WO1997041124A1 (en) | 1996-04-26 | 1997-04-24 | Process for the preparation of tetrahydro-indolizines |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE207921T1 true ATE207921T1 (de) | 2001-11-15 |
Family
ID=26447288
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT97919674T ATE207921T1 (de) | 1996-04-26 | 1997-04-24 | Verfahren zur herstellung von tetrahydroindolizinen |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US6172230B1 (de) |
| EP (1) | EP0897924B1 (de) |
| KR (1) | KR20000064811A (de) |
| CN (2) | CN1087296C (de) |
| AT (1) | ATE207921T1 (de) |
| AU (1) | AU2406097A (de) |
| DE (1) | DE69707860T2 (de) |
| DK (1) | DK0897924T3 (de) |
| ES (1) | ES2166991T3 (de) |
| PT (1) | PT897924E (de) |
| WO (1) | WO1997041124A1 (de) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU6870500A (en) * | 1999-09-06 | 2001-04-10 | Takeda Chemical Industries Ltd. | Process for the preparation of 2,3-dihydroazepine derivatives |
| US7595400B2 (en) | 2003-02-21 | 2009-09-29 | Chugai Seiyaku Kabushiki Kaisha | Process for the preparation of hexacyclic compounds |
| US7910593B2 (en) | 2004-04-09 | 2011-03-22 | Chugai Seiyaku Kabushiki Kaisha | Water-soluble prodrugs |
| TW200744603A (en) | 2005-08-22 | 2007-12-16 | Chugai Pharmaceutical Co Ltd | Novel anticancer concomitant drug |
| US12098961B2 (en) * | 2018-06-29 | 2024-09-24 | Tecnimed S.R.L. | Non-contact infrared thermometer |
| CN110204482A (zh) * | 2019-05-23 | 2019-09-06 | 久泰能源(准格尔)有限公司 | 一种4-羟基吡啶-2,6-二羧酸的制备方法 |
| CA3146560A1 (en) | 2019-07-10 | 2021-01-14 | Cybrexa 2, Inc. | Peptide conjugates of cytotoxins as therapeutics |
| MY209459A (en) | 2019-07-10 | 2025-07-09 | Cybrexa 3 Inc | Peptide conjugates of microtubule-targeting agents as therapeutics |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4304728A (en) * | 1979-04-05 | 1981-12-08 | Lilly Industries Limited | 6-Substituted pyranone compounds and their use as pharmaceuticals |
| US4894456A (en) * | 1987-03-31 | 1990-01-16 | Research Triangle Institute | Synthesis of camptothecin and analogs thereof |
| US4981968A (en) * | 1987-03-31 | 1991-01-01 | Research Triangle Institute | Synthesis of camptothecin and analogs thereof |
| US5364858A (en) * | 1987-03-31 | 1994-11-15 | Research Triangle Institute | Camptothecin analogs as potent inhibitors of topoisomerase I |
| US5227380A (en) * | 1987-03-31 | 1993-07-13 | Research Triangle Institute | Pharmaceutical compositions and methods employing camptothecins |
| US5244903A (en) * | 1987-03-31 | 1993-09-14 | Research Triangle Institute | Camptothecin analogs as potent inhibitors of topoisomerase I |
| US5106742A (en) * | 1987-03-31 | 1992-04-21 | Wall Monroe E | Camptothecin analogs as potent inhibitors of topoisomerase I |
| US5122526A (en) * | 1987-03-31 | 1992-06-16 | Research Triangle Institute | Camptothecin and analogs thereof and pharmaceutical compositions and method using them |
-
1997
- 1997-04-24 PT PT97919674T patent/PT897924E/pt unknown
- 1997-04-24 CN CN97194126A patent/CN1087296C/zh not_active Expired - Fee Related
- 1997-04-24 KR KR1019980707765A patent/KR20000064811A/ko not_active Ceased
- 1997-04-24 WO PCT/JP1997/001428 patent/WO1997041124A1/ja not_active Ceased
- 1997-04-24 DE DE69707860T patent/DE69707860T2/de not_active Expired - Fee Related
- 1997-04-24 AU AU24060/97A patent/AU2406097A/en not_active Abandoned
- 1997-04-24 US US09/147,183 patent/US6172230B1/en not_active Expired - Fee Related
- 1997-04-24 DK DK97919674T patent/DK0897924T3/da active
- 1997-04-24 ES ES97919674T patent/ES2166991T3/es not_active Expired - Lifetime
- 1997-04-24 AT AT97919674T patent/ATE207921T1/de not_active IP Right Cessation
- 1997-04-24 EP EP97919674A patent/EP0897924B1/de not_active Expired - Lifetime
-
2000
- 2000-08-18 US US09/640,879 patent/US6337400B1/en not_active Expired - Fee Related
-
2002
- 2002-02-08 CN CN02104573A patent/CN1373130A/zh active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| EP0897924B1 (de) | 2001-10-31 |
| US6172230B1 (en) | 2001-01-09 |
| AU2406097A (en) | 1997-11-19 |
| CN1216992A (zh) | 1999-05-19 |
| DE69707860T2 (de) | 2002-04-11 |
| US6337400B1 (en) | 2002-01-08 |
| KR20000064811A (ko) | 2000-11-06 |
| EP0897924A4 (de) | 1999-07-07 |
| DK0897924T3 (da) | 2001-11-19 |
| EP0897924A1 (de) | 1999-02-24 |
| PT897924E (pt) | 2002-03-28 |
| CN1373130A (zh) | 2002-10-09 |
| WO1997041124A1 (en) | 1997-11-06 |
| DE69707860D1 (de) | 2001-12-06 |
| ES2166991T3 (es) | 2002-05-01 |
| CN1087296C (zh) | 2002-07-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE174903T1 (de) | Neues verfahren zur herstellung von 7- (substituierten)-9-((substistuierter | |
| ATE194601T1 (de) | Verfahren zur herstellung von pyrimidinverbindungen | |
| ATE194614T1 (de) | Verfahren zur herstellung von 3- arylbenzofuranonen | |
| ATE135683T1 (de) | Verfahren zur herstellung von carbaminsäureestern verfahren zur herstellung von carbaminsäureester | |
| DE69707860D1 (de) | Verfahren zur herstellung von tetrahydroindolizinen | |
| DE60219501D1 (de) | Verfahren zur herstellung von 3-hydroxy-n-1,6-trialkyl-4-oxo-1,4-dihydropyridin-2-carboxamide | |
| ATE384067T1 (de) | Verfahren zur herstellung von 3-cephemderivaten | |
| ATE240286T1 (de) | Verfahren zur herstellung von 1-aryl-3- cyclopropyl-1,3-propandionen | |
| ATE165824T1 (de) | Verfahren zur herstellung von 2-perfluoroalkyl-3- oxazolin-5-one | |
| ATE203525T1 (de) | Verfahren zur herstellung von 4-amino-1,2,4- triazolen | |
| DE3767618D1 (de) | Verfahren zur herstellung von tetrafluorphthalsaeure. | |
| ATE286870T1 (de) | Verfahren zur herstellung von estern | |
| ATE139765T1 (de) | Verfahren zur herstellung von halogenanthranilsäuren | |
| ATE293098T1 (de) | Verfahren zur herstellung von beta-ketonitrilen | |
| ATE159016T1 (de) | Verfahren zur herstellung von 5-amino-2,2-dialkyl-1,3-dioxan | |
| ATE365152T1 (de) | Verfahren zur herstellung fluorierter benzoesäuren | |
| ATE166048T1 (de) | Verfahren zur herstellung von prostaglandin e | |
| ATE299498T1 (de) | Verfahren zur herstellung von imidazolderivaten | |
| ATE131483T1 (de) | Verfahren zur herstellung von penemen | |
| DE69906009D1 (de) | Verfahren zur Herstellung von 2-Alkyliden-4-Bromacetessigsäureestern | |
| ATE244228T1 (de) | Verfahren zur herstellung von chloroacetylaminothiazoleaceticsäure derivate | |
| ATE267167T1 (de) | Verfahren zur herstellung von 7-azabicyclo (4.1.0)-hept-3-ene-3-carbonsäureestern | |
| ATE240937T1 (de) | Gamma-oxohomophenylalanin derivate und ein verfahren zur herstellung von homophenylalanin derivaten durch reduktion derselben | |
| DE69030884D1 (de) | Verfahren zur herstellung von norbornan-sulfonamidderivat | |
| DE60028998D1 (de) | Verfahren zur herstellung einer benzylamin-verbindung |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification | ||
| REN | Ceased due to non-payment of the annual fee |